17:22 EST Black Diamond Therapeutics (BDTX) files $500M mixed securities shelf
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDTX:
- Promising Clinical Developments and Strong Financials Justify Buy Rating for Black Diamond Therapeutics
- Black Diamond Therapeutics Reports Positive Financial Turnaround
- Black Diamond Therapeutics reports Q3 EPS (15c), consensus (23c)
- Black Diamond Therapeutics sees cash runway into 4Q27
- Black Diamond Therapeutics resumed with a Buy at Stifel